Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA189355
Max Phase: Preclinical
Molecular Formula: C18H17NO4S
Molecular Weight: 343.40
Molecule Type: Small molecule
Associated Items:
ID: ALA189355
Max Phase: Preclinical
Molecular Formula: C18H17NO4S
Molecular Weight: 343.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(C(=O)c2c(N)sc3ccccc23)cc(OC)c1OC
Standard InChI: InChI=1S/C18H17NO4S/c1-21-12-8-10(9-13(22-2)17(12)23-3)16(20)15-11-6-4-5-7-14(11)24-18(15)19/h4-9H,19H2,1-3H3
Standard InChI Key: JQEVJXXMFRRASE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 343.40 | Molecular Weight (Monoisotopic): 343.0878 | AlogP: 3.74 | #Rotatable Bonds: 5 |
Polar Surface Area: 70.78 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.82 | CX LogD: 3.82 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.71 | Np Likeness Score: -0.40 |
1. Romagnoli R, Baraldi PG, Jung MK, Iaconinoto MA, Carrion MD, Remusat V, Preti D, Tabrizi MA, Francesca F, De Clercq E, Balzarini J, Hamel E.. (2005) Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles., 15 (18): [PMID:16005627] [10.1016/j.bmcl.2005.06.022] |
2. Romagnoli R, Baraldi PG, Carrion MD, Lopez Cara C, Preti D, Fruttarolo F, Pavani MG, Tabrizi MA, Tolomeo M, Grimaudo S, Di Cristina A, Balzarini J, Hadfield JA, Brancale A, Hamel E.. (2007) Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization., 50 (9): [PMID:17419607] [10.1021/jm070050f] |
3. Romagnoli R, Baraldi PG, Carrion MD, Cruz-Lopez O, Cara CL, Tolomeo M, Grimaudo S, Di Cristina A, Pipitone MR, Balzarini J, Kandil S, Brancale A, Sarkar T, Hamel E.. (2008) Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization., 18 (18): [PMID:18725179] [10.1016/j.bmcl.2008.08.006] |
Source(1):